FDA Adverse Event Injury Summary report: N

PROMUS PREMIER?

MDR report key: 3913273 · Received July 3, 2014

Report

Report Number
2134265-2014-03846
Event Type
Injury
Date Received
July 3, 2014
Date of Event
June 9, 2014
Report Date
June 9, 2014
Manufacturer
BOSTON SCIENTIFIC - GALWAY
Product Code
NIQ
PMA / PMN Number
P110010
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AGE AT TIME OF EVENT: 18 YEARS OR OLDER. DEVICE IS A COMBINATION PRODUCT. DEVICE EVALUATED BY MFR.: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT STENT DAMAGE POST DEPLOYMENT AFTER SECONDARY DEVICE INTERACTION OCCURRED. THE 100% STENOSED TARGET LESION WAS LOCATED IN THE MILDLY TORTUOUS SAPHENOUS VEIN GRAFT (SVG) TO AN OBTUSE MARGINAL ARTERY. DURING PROCEDURE THE PHYSICIAN USED A NON-BSC WIRE BUT HE ENDED UP PLACING A 3.50X38MM PROMUS PREMIER STENT WIRE TO TREAT THE LESION. AS HE WAS RETRIEVING THE NON-BSC WIRE THE END PART OF IT DEFORMED THE PROXIMAL END OF THE PROMUS STENT. THE NON-BSC DEVICE GOT ENTANGLED IN THE STENT BUT WAS ABLE TO REMOVE THE NON-BSC WIRE OUT OF THE STENT, THE NON BSC WIRE WAS PUT DOWN TO BRING A BALLOON BUT IT THEN DEFORMED THE STENT DOWN TO APPROXIMATELY 16MM-20MM IN LENGTH. THE PROCEDURE WAS COMPLETED WITH THIS DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS IS STABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
390117 PROMUS PREMIER? STENT, CORONARY, DRUG-ELUTING NIQ BOSTON SCIENTIFIC - GALWAY H7493952838350 16826184

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention